Pune, India -- (SBWIRE) -- 03/06/2019 -- The Asia Pacific narcolepsy market is expected to grow at the highest rate during the forecast period owing higher number of research & development and increasing investments on sleep related neurological disorders. In addition, emergence of new local players with competitive drug portfolio are expected to fuel the market growth in Asia Pacific region.

Get Sample data tables and in-depth TOC of the narcolepsy market (2019–2017) @ https://www.theinsightpartners.com/sample/TIPRE00003326/

Type Insights
The narcolepsy market by type is segmented into narcolepsy with cataplexy, narcolepsy without cataplexy, and secondary cataplexy. In 2018, the narcolepsy with cataplexy segment held a largest market share of 65.1% of the narcolepsy market, by type. This segment is also expected to dominate the market in 2027 owing to its significant prevalence among patients suffering with narcolepsy. Episodes of cataplexy are reported to be encountered among 55-60% of patients suffering with narcolepsy. Moreover, the similar segment is anticipated to also witness the fastest growth rate of 9.7% during the forecast period, 2019 to 2027 owing to the increasing demand for drugs to treat the disease.

Product Insights
The global narcolepsy market on the basis of product is segmented into sodium oxybate, central nervous system (CNS) stimulants, and antidepressants. Sodium oxybate segment is anticipated to grow at a CAGR of 9.8% during the forecast period. Sodium oxybate is the one of the primary medication recommended by specialists to patients suffering with narcolepsy. The high cost of the branded counterparts, availability of reimbursement with certain regions as well as approval of the drug in majority of the top markets is likely to contribute to the growth and dominance of the segment. Sodium is oxybate is also expected to exhibit highest growth witnessing a robust CAGR over the forecast years.

The report segments the global narcolepsy market as follows:

Global Narcolepsy Market - By Type

- Narcolepsy with Cataplexy
- Narcolepsy without Cataplexy
- Secondary Cataplexy

Global Narcolepsy Market – By ProductSodium Oxybate

- Central Nervous System (CNS) Stimulants
- Antidepressants

Global Narcolepsy Market – By Distribution Channel

- Hospital Pharmacies
- Retail Pharmacies

Global Narcolepsy Market – By Geography

- North America
o U.S.
o Canada
o Mexico

- Europe
o U.K.
o Germany
o France
o Italy
o Spain

- Asia Pacific (APAC)
o Japan
o China
o India
o Australia
o South Korea

- Middle East & Africa (MEA)
o South Africa
o UAE
o Saudi Arabia

- South & Central America (SCAM)
o Brazil
o Argentina

Get 10% Free Customization on Purchase @ https://www.theinsightpartners.com/buy/TIPRE00003326/

Reasons To Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the narcolepsy market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global narcolepsy treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

About The Insight Partners
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Automotive, Electronics and Chemical industries.